Screener
Emergent Biosolutions EBS Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Emergent Biosolutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001367644-26-000082
FAQ
- What is Emergent Biosolutions's restricted cash?
- Emergent Biosolutions (EBS) reported restricted cash of $1.2M in Q2 2026.
- How has Emergent Biosolutions's restricted cash changed year-over-year?
- Emergent Biosolutions's restricted cash decreased by 67.6% year-over-year, from $3.7M to $1.2M.
- What is the long-term trend for Emergent Biosolutions's restricted cash?
- Over 5 years (2020 to 2025), Emergent Biosolutions's restricted cash has grown at a 79.2% compound annual growth rate (CAGR), from $200K to $3.7M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Emergent Biosolutions's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude